HDAC inhibitor suppresses proliferation and tumorigenicity of drug-resistant chronic myeloid leukemia stem cells through regulation of hsa-miR-196a targeting BCR/ABL1-Reference-Cited by-同舟云学术

HDAC inhibitor suppresses proliferation and tumorigenicity of drug-resistant chronic myeloid leukemia stem cells through regulation of hsa-miR-196a targeting BCR/ABL1

Published:2018-09 Issue:2 Volume:370 Page:519-530
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Bamodu Oluwaseun Adebayo,Kuo Kuang-Tai,Yuan Li-Ping,Cheng Wei-Hong,Lee Wei-Hwa,Ho Yuan-Soon,Chao Tsu-Yi,Yeh Chi-Tai

Funder

National Science Council of Taiwan

Taipei Medical University

Taipei Medical University -National Taiwan University of Science and Technology Joint Research Program

Publisher

Elsevier BV

Subject

Cell Biology

Reference35 articles.

1. Characterization of chronic myeloid leukemia stem cells;Gerber;Am. J. Hematol.,2011

2. Characterization of cancer stem cells in chronic myeloid leukaemia;Jørgensen;Biochem. Soc. Trans.,2007

3. Molecular and structural characterization of the SH3 domain of AHI-1 in regulation of cellular resistance of BCR/ABL (+) chronic myeloid leukemia cells to tyrosine kinase inhibitors;Liu;Proteomics,2012

4. The implication of cancer progenitor cells and the role of epigenetics in the development of novel therapeutic strategies for chronic myeloid leukemia;Tortorella;Antioxid. Redox Signal.,2015

5. What are the challenges in 2016 regarding resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and cancer?;Lewis;Hematol. Oncol.,2016

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel targeted therapies in chronic myeloid leukemia;Pharmaceutical Science Advances;2024-09

2. HDAC inhibitor chidamide overcomes drug resistance in chronic myeloid leukemia with the T315i mutation through the Akt–autophagy pathway;Human Cell;2023-05-24

3. SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia;Clinical Epigenetics;2022-12

4. A distinct subpopulation of leukemia initiating cells in acute precursor B lymphoblastic leukemia: quiescent phenotype and unique transcriptomic profile;Frontiers in Oncology;2022-09-21

5. OCT4-mediated transcription confers oncogenic advantage for a subset of gastric tumors with poor clinical outcome;Functional & Integrative Genomics;2022-08-21